Scientific Statements

Policy Conference Documents & Joint Task Force Statements

Policy Conference Documents

• Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Stramba-Badiale M, Fox K M, Priori S G, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K, Tendera M. Eur Heart J 2006;27:994-1005
• Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F. Eur Heart J 2005;26:2733-41
• The Need for Resources for Clinical Reseach. Proceedings of a Policy Conference held at the European Heart House, 27-28 June 2002: Executive Summary
  Bassand JB, Martin J, Rydén l, Simoons M
  Eur Heart J 2003;24:1171-73 
  The Need for Resources for Clinical Reseach: the European Society of Cardiology calls for European, international collaboration
  Bassand JB , Martin J , Rydén L, Simoons M
  Lancet 2002;360:1866-69
• ESC-ERC Policy Conference on Use of AEDs 
  ESC-ERC recommendations for the use of automated external defibrillators (AEDS) in Europe. Priori SG, Bossaert LL,  Chamberlain DA, Napolitano C, Arntz HR, Koster RW, Monsieurs KG, Capucci A, Wellens HJ
  Eur Heart J 2004;25:437-445
  • Supplement 1
  • Supplement 2
  • Supplement 3 
    
• The Potential for QT Prolongation and Proarrhythmia by Non-antiarrhythmic Drugs. Clinical and Regulatory Implications. 
  Report on a Policy Conference of the ESC.
  Eur Heart J 2000;21
  
• Re-Use of Devices in Cardiology. Proceedings from a Policy Conference at the European Heart House, February 5-6, 1998
  Prof. Lars Rydén, President of the European Society of Cardiology
  Eur Heart J 1998;19:1628-131

Task Force Statements

• ESC Position paper on Anticoagulants in heart disease: current status and perspectives - R. De Caterina; S. Husted; L. Wallentin; G. Agnelli; F. Bachmann; C. Baigent; J. Jespersen; S. D. Kristensen; G. Montalescot; A. Siegbahn; F. W.A. Verheugt; J. Weitz . EHJ 2007;28:880-913
• Legal implications of Medical Guidelines -P. J. Schwartz, G. Breithardt, A. J. Howard, D. G. Julian, N. Reherqvist- Ahlberg - EHJ 1999;20:1552-1157 
• Driving and Heart Disease - M.C. Petch - EHJ 1998;19:1165-1172
• Pre-Hospital Management of Acute Heart Attacks -H.Arntz, L. Bossaert, P. Carli, D. Chamberlain., M. Davies, M. Dellborg, W. Dick, T. Haghfelt., S. Hapnes, R. Juchems, H. Loewel, R. Koster, A. Leizorovicz, M. Marzilli, J. Rawles, C. Robertson, M. Ruano - EHJ 1998;19:1140-1164
• Clinical Role of Magnetic Resonance in Cardiovascular Disease -S. Neubauer, D. Revel, A. de Roos, A. van Rossum, G. von Schulthess, U. Sechtem, L. Sieverding, R. Underwood, E. van der Wall - EHJ 1998;19:19-39
• Burden of Burden of Cardiovascular Diseases Diseases Mortality in Europe - S.Sans, H. Kesteloot., D. Kromhout on behalf of the Task Force - EHJ 1997;18:1231-1248
• Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use -A.J. Camm, M Malik (Chairpersons) EHJ 1996;17:354-381
• Clinical Investigation of anti-arrhythmic devices
  A statement for healthcare professionals from a joint task force of the North American Society of Pacing and Electrophysiology (NASPE), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology (ESC)
  Eur Heart J 1995;16:446-59
  PACE - Pacing and Electrophysiology 1995;18:637-654
  JACC 1995;2:961 - 973 Circulation 1995;91:2097-2109